Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Electroacupuncture With or Without Combined Warm Needling for Tinnitus

N/ACompletedNCT05557357
Lai Fun HO, PhD90 enrolled

Overview

This randomized controlled trial aims to evaluate the efficacy and safety of either electroacupuncture alone or combined with warm needling in reducing tinnitus loudness and improving the impairment caused by tinnitus in Hong Kong.

This study is a prospective, multicenter, assessor-blind, three-arm, parallel-group, randomized waitlist-controlled trial. A total of 90 eligible subjects with tinnitus will be recruited and randomly assigned to electroacupuncture (EA), electroacupuncture combined with warm needling (EAWN) or waitlist control with n=30 subjects each group. The entire study period will last for 10 weeks, including a 5-week intervention period and a 5-week follow-up period. Outcome measures include the loudness of tinnitus and the Tinnitus Handicap Inventory. Any adverse event will be observed and recorded for safety assessment. The study findings will provide evidence to determine the efficacy and safety of electroacupuncture with or without combined warm needling for tinnitus in Hong Kong.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

90

Conditions

TinnitusTinnitus, Subjective

Interventions

Electroacupuncture (EA)PROCEDURE

Electroacupuncture (EA) treatment following standardized procedures will be conducted for 2 sessions per week for 5 consecutive weeks. Each session of treatment will last for 25 min. The acupoints that will be stimulated are Tinggong (SI19) and Yifeng (TE17) of the affected side, Baihui (GV20) and Yintang (GV24+), bilateral posterior temporal line (MS11), and Zhongzhu (TE3) and Zusanli (ST36) of the affected side. For electroacupuncture (EA), electrical stimulation will be applied using an EA apparatus, with pairs of electrodes connecting the needles at ipsilateral SI19 and TE17, GV20 and GV24+, and bilateral MS11.

Electroacupuncture Combined With Warm Needling (EAWN)PROCEDURE

Electroacupuncture combined with warm needling (EAWN) treatment following standardized procedures will be conducted for 2 sessions per week for 5 consecutive weeks. Each session of treatment will last for 25 min. The acupoints that will be stimulated are SI19 and TE17 (affected side), GV20 and GV24+, bilateral MS11, and TE3 and ST36 (affected side). For electroacupuncture (EA), electrical stimulation will be applied using an EA apparatus, with pairs of electrodes connecting the needles at ipsilateral SI19 and TE17, GV20 and GV24+, and bilateral MS11. For warm needling (WN), two moxa sticks will be ignited and attached one by one to the needle handle of each acupoint of SI19 and TE17.

Waitlist ControlOTHER

No treatment will be provided during the 10-week waiting period after baseline assessment.

Eligibility

Sex: ALLMin age: 50 YearsMax age: 70 Years
Medical Language ↔ Plain English
Inclusion Criteria: * Diagnosed with subjective tinnitus; * Male and female, age 50 to 70 years old; * Unilateral or bilateral tinnitus for 0.5-24 months; * Loudness of tinnitus rated 3 points or more on a 0-10 numeric rating scale (NRS) at the time of enrollment; and * Agree to sign the informed consent form voluntarily. Exclusion Criteria: * Known disease conditions that could cause tinnitus such as Meniere's syndrome, acoustic duct diseases, and middle ear diseases; * History of head trauma; * Currently using cardiac pacemaker or metal implants; * Known severe cardiac diseases, cerebrovascular diseases, renal diseases, or hematologic diseases; * Known severe psychiatric or psychological disorder; * Pregnant, lactation or expecting a pregnancy during the study period; * Severe needle phobia; * Known hypersensitive reaction after acupuncture and moxibustion treatment or an inability to cooperate with the acupuncture and moxibustion procedure; * Incapable to understand and answer the questions of the assessors in the study; and * Other factors deemed unsuitable for inclusion in the study by investigators.

Locations (3)

Pok Oi Hospital-Chinese Medicine Polyclinic (Tin Shui Wai)

Hong Kong, China

Pok Oi Hospital-The Chinese University of Hong Kong Chinese Medicine Clinic cum Training ad Research Centre (Yuen Long District)

Hong Kong, China

Pok Oi Hospital-The Chinese University of Hong Kong Chinese Medicine Clinic cum Training and Research Centre (Shatin District)

Hong Kong, China

Outcomes

Primary Outcomes

Change in Tinnitus Loudness

A 0-10 numeric rating scale (NRS) will be used for rating loudness of tinnitus. Higher score indicates greater tinnitus loudness and its influence.

Time frame: Baseline, Week 5, and Week 10

Secondary Outcomes

Change in Tinnitus Handicap Inventory (THI)

THI is a 25-item self-report measure to determine tinnitus handicap severity with good reliability and validity. The THI total score ranges from 0 to 100, with higher score denoting higher level of severity.

Time frame: Baseline, Week 5, and Week 10

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.